Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syros Pharmaceuticals, Inc. (SYRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 7,348 shares
@ $3.95, valued at
$29k
|
|
| 07/18/2023 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 689 shares
@ $3.5, valued at
$2.4k
|
|
| 06/02/2023 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| Eckhardt Sue Gail (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 06/02/2023 |
4
| Dunsire Deborah (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
Granted 4,000 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| Alles Mark J (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
Granted 4,000 restricted stock units
@ $0 |
|
| 06/02/2023 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
Granted 4,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 658 shares
@ $2.58, valued at
$1.7k
Exercised 2,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Stephens Kristin (Chief Development Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 623 shares
@ $2.58, valued at
$1.6k
Exercised 2,000 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,852 shares
@ $2.58, valued at
$4.8k
Exercised 6,000 restricted stock units
@ $0 |
|
| 10/13/2022 |
4
| Quirk Gerald E (Chief Legal Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Chee Conley (Chief Commercial Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Stephens Kristin (Chief Development Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Olson Eric R (Chief Scientific Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 44,500 options to buy
@ $6.73, valued at
$299.5k
Granted 34,000 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Roth David (Chief Medical Officer) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 49,750 options to buy
@ $6.73, valued at
$334.8k
Granted 37,750 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Haas Jason (CFO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 49,750 options to buy
@ $6.73, valued at
$334.8k
Granted 37,750 restricted stock units
@ $0 |
|
| 10/11/2022 |
4
| Simonian Nancy A (President & CEO) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 115,000 options to buy
@ $6.73, valued at
$774k
Granted 80,250 restricted stock units
@ $0 |
|
| 10/03/2022 |
4
| TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Bought 2,932 shares
@ $5.7196, valued at
$16.8k
Bought 14,000 shares
@ $6.3704, valued at
$89.2k
|
|
| 09/19/2022 |
4
| Young Richard A (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
Granted 8,000 restricted stock units
@ $0 |
|
| 09/19/2022 |
4
| WIRTH PETER (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| TYSON TIMOTHY (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| Fanucci Marsha (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| Eckhardt Sue Gail (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| Dunsire Deborah (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
4
| Alles Mark J (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
Granted 8,000 restricted stock units
@ $0 |
|
| 09/19/2022 |
4
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
Granted 8,000 restricted stock units
@ $0 |
|
|
|
|